Plexin-B2 in psoriasis; a clinical and immunohistochemical study

Area of Science:

• Immunodermatology
• Molecular Biology
• Inflammation Research

Background:

• Psoriasis is a chronic inflammatory, immune-mediated skin disease.
• Plexins are transmembrane proteins crucial for immune regulation and inflammation.
• Plexin-B2's role in plaque psoriasis pathogenesis requires further investigation.

Purpose of the Study:

• To investigate the immunohistochemical expression of Plexin-B2 in lesional and perilesional skin of plaque psoriasis patients.
• To correlate Plexin-B2 expression levels with psoriasis severity using the Psoriasis Area and Severity Index (PASI) score.

Main Methods:

• A case-control study involving 30 patients with psoriasis vulgaris and 20 healthy controls.
• Histopathological and immunohistochemical analysis of skin biopsies (lesional, perilesional, and control).
• Quantitative assessment of Plexin-B2 expression in keratinocytes and dermal inflammatory cells.

Main Results:

• Significant stepwise overexpression of Plexin-B2 was observed in keratinocytes from controls to perilesional and lesional psoriatic skin (P < .001).
• Plexin-B2 was significantly overexpressed in dermal inflammatory cells of lesional psoriatic skin compared to controls (P < .001).
• A significant positive correlation was found between Plexin-B2 expression and psoriasis severity (r = 0.557; P < .001).

Conclusions:

• Plexin-B2 is significantly upregulated in plaque psoriasis, indicating its involvement in the disease.
• Plexin-B2 may promote both skin inflammation and keratinocyte proliferation in psoriasis vulgaris.
• Plexin-B2 represents a potential therapeutic target for psoriasis treatment.